Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 1/19/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Sanjay Batra

Wrong Dr. Sanjay Batra?
 
Background

Employment History

Education

  • Ph.D. , Medical Physiology
    University of Ottawa , Canada
13 Total References
Web References
Garnet BioTherapeutics ...
www.prnewswire.com, 1 Mar 2010 [cached]
Garnet BioTherapeutics Appoints Sanjay Batra, Ph.D., F.A.C.C., as Senior Vice President, Development
...
Garnet BioTherapeutics Appoints Sanjay Batra, Ph.D., F.A.C.C., as Senior Vice President, Development
...
MALVERN, Pa., March 1 /PRNewswire/ -- Garnet BioTherapeutics, Inc., a regenerative medicine company focused on developing products that speed healing and reduce scarring after surgery or dermatologic procedures, today announced the appointment of Sanjay Batra, Ph.D., F.A.C.C., as Senior Vice President, Development.  Dr. Batra has more than 15 years of research and development experience in both the biotechnology and pharmaceutical industries, including nine years at Johnson & Johnson.  In his role at Garnet BioTherapeutics, Dr. Batra will oversee all clinical development programs including the upcoming Phase II study of the Company's lead compound GBT009, which is under investigation as a post-surgical wound healing agent.  
"We believe Sanjay will be an invaluable asset to the Garnet team as we advance our GBT009 program as a therapy to enhance dermal healing and reduce scarring after surgery," said Gerri Henwood, CEO of Garnet.  "Sanjay brings a solid scientific background and a proven track record in global product development based on his experience at Centocor and J&J and more than 15 years in the healthcare industry. "We believe Sanjay will be an invaluable asset to the Garnet team as we advance our GBT009 program as a therapy to enhance dermal healing and reduce scarring after surgery," said Gerri Henwood, CEO of Garnet.  "Sanjay brings a solid scientific background and a proven track record in global product development based on his experience at Centocor and J&J and more than 15 years in the healthcare industry.
...
We are confident that Sanjay will help us realize the potential of our cell-based therapy platform."
"I am excited to join Garnet BioTherapeutics during such a critical stage of the company's evolution.  Gerri has built a first class team here and I look forward to joining forces as we achieve our goal of becoming a leader in the field of regenerative medicine," said Dr. Batra.
...
Since joining the Johnson & Johnson family of companies in 2001, Dr. Batra held positions of increasing responsibility in both clinical development and project management at Centocor, Inc.  Most recently, Dr. Batra was Vice President, R&D Pharmaceuticals, Asia-Pacific and Japan for J&J, where he was responsible for ensuring global connectivity across all therapeutic areas.
Prior to his time at J&J, Dr. Batra was in clinical development at Bracco Diagnostics, and in preclinical and clinical development at Alliance Pharmaceuticals.  Dr. Batra obtained his Ph.D. in Medical Physiology from the University of Ottawa, Canada and completed his post-doctoral training in Sapporo, Japan and Bern, Switzerland. Dr. Batra is the recipient of numerous awards and has published over 100 papers and abstracts in the area of cardiovascular medicine and physiology.
People & Places
www.the-aps.org, 1 June 2001 [cached]
Having affiliated with Centocor, Inc., Malvern, PA, as Associate Director of Clinical Development, Sanjay Batra has moved from Bracco Diagnostics, Inc., Department of Clinical Development, Princeton, NJ.
Appoints Sanjay Batra, ...
www.biospace.com, 1 Mar 2010 [cached]
Appoints Sanjay Batra, Ph.D., F.A.C.C., as Senior Vice President, Development 3/1/2010
MALVERN, Pa., March 1 /PRNewswire/ -- Garnet BioTherapeutics, Inc., a regenerative medicine company focused on developing products that speed healing and reduce scarring after surgery or dermatologic procedures, today announced the appointment of Sanjay Batra, Ph.D., F.A.C.C., as Senior Vice President, Development. Dr. Batra has more than 15 years of research and development experience in both the biotechnology and pharmaceutical industries, including nine years at Johnson & Johnson. In his role at Garnet BioTherapeutics, Dr. Batra will oversee all clinical development programs including the upcoming Phase II study of the Company's lead compound GBT009, which is under investigation as a post-surgical wound healing agent.
...
Gerri has built a first class team here and I look forward to joining forces as we achieve our goal of becoming a leader in the field of regenerative medicine," said Dr. Batra.
Prior to his time at J&J, Dr. Batra was in clinical development at Bracco Diagnostics, and in preclinical and clinical development at Alliance Pharmaceuticals. Dr. Batra obtained his Ph.D. in Medical Physiology from the University of Ottawa, Canada and completed his post-doctoral training in Sapporo, Japan and Bern, Switzerland. Dr. Batra is the recipient of numerous awards and has published over 100 papers and abstracts in the area of cardiovascular medicine and physiology.
AIS's Health Business Daily
www.aishealth.com, 2 Mar 2010 [cached]
Garnet BioTherapeutics, Inc., a regenerative medicine company, named Sanjay Batra senior vice president of development. Batra was vice president of Asia-Pacific and Japan at Johnson & Johnson Pharmaceutical Research and Development, LLC....CDC appointed Judy Monroe, M.D., director of the Office of State, Tribal, Local and Territorial Support.
Garnet BioTherapeutics ...
www.silobreaker.com [cached]
Garnet BioTherapeutics Appoints Sanjay Batra, Ph.D., F.A.C.C., as
...
Garnet BioTherapeutics, Inc., a regenerative medicine company focused on developing products that speed healing and reduce scarring after surgery or dermatologic procedures, today announced the appointment of Sanjay Batra, Ph.D., F.A.C.C., as Senior Vice ... [Published 12 hours ago by PR Newswire via MSN Money]
...
"I am excited to join Garnet BioTherapeutics during such a critical stage of the company's evolution. $ Gerri has built a first class team here and I look forward to joining forces as we achieve our goal of becoming a leader in the field of regenerative medicine" said Dr. Batra
...
Garnet BioTherapeutics Appoints Sanjay Batra, Ph.D., F.A.C.C., as [PR Newswire via MSN Money - 12 hours ago]
...
Garnet BioTherapeutics Appoints Sanjay Batra, P... [PR Newswire via MSN Money - 12 hours ago]
Other People with the name "Batra":
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.